05 February 2025
05 February 2025
Industry associations react to President Trump’s tariffs and what they could mean for pharmaceutical supply.
The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.
Developers celebrate gains for advances with radiopharmaceuticals while regulators and isotope suppliers work to keep up.
Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.
The move strengthens Jabil's pharmaceutical solutions offerings.
The company is poised to address significant medical and economic challenges in both asthma and COPD.
David Tran and his team have identified "master regulators" within glioblastoma, leveraging AI technology.
The move follows the company’s merger with Tergus Pharma in July 2024.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
